Advanced company searchLink opens in new window

VIMELA THERAPEUTICS LIMITED

Company number 13611487

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
06 Nov 2023 PSC08 Notification of a person with significant control statement
06 Nov 2023 MA Memorandum and Articles of Association
06 Nov 2023 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
06 Nov 2023 SH08 Change of share class name or designation
06 Nov 2023 SH08 Change of share class name or designation
27 Oct 2023 AA01 Current accounting period extended from 30 September 2023 to 31 December 2023
27 Oct 2023 PSC07 Cessation of Medicxi Iii Lp as a person with significant control on 18 October 2023
27 Oct 2023 AP01 Appointment of Dr Thibaud Portal as a director on 18 October 2023
27 Oct 2023 TM01 Termination of appointment of Francesco De Rubertis as a director on 18 October 2023
27 Oct 2023 TM01 Termination of appointment of Michele Ollier Bauer as a director on 18 October 2023
27 Oct 2023 TM01 Termination of appointment of Andrea Epperly as a director on 18 October 2023
12 Sep 2023 CS01 Confirmation statement made on 8 September 2023 with updates
01 Aug 2023 SH01 Statement of capital following an allotment of shares on 31 July 2023
  • USD 205.4124
15 Jun 2023 AA Accounts for a small company made up to 30 September 2022
15 May 2023 RP04SH01 Second filing of a statement of capital following an allotment of shares on 16 June 2022
  • USD 142.7102
12 Dec 2022 AP01 Appointment of Francesco De Rubertis as a director on 8 December 2022
08 Dec 2022 TM01 Termination of appointment of Nicholas Alexander Williams as a director on 8 December 2022
16 Sep 2022 CS01 Confirmation statement made on 8 September 2022 with updates
16 Sep 2022 PSC02 Notification of Medicxi Iii Lp as a person with significant control on 23 December 2021
16 Sep 2022 PSC09 Withdrawal of a person with significant control statement on 16 September 2022
16 Jun 2022 SH01 Statement of capital following an allotment of shares on 16 June 2022
  • USD 142.8992
  • ANNOTATION Clarification a second filed SH01 was registered on 15/05/23
16 Jun 2022 CH01 Director's details changed for Ms Michele Ollier Baum on 1 June 2022
13 May 2022 SH01 Statement of capital following an allotment of shares on 11 May 2022
  • USD 116.0112
29 Apr 2022 SH01 Statement of capital following an allotment of shares on 5 April 2022
  • USD 113.3362
25 Jan 2022 AP01 Appointment of Mr Nicholas Alexander Williams as a director on 22 December 2021